Stem Cell Therapy
Japanese Biotech Raises $37 Million in Series C to Develop Stem Cell Therapy for Heart Failure
2021-06-13
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19